Quality of life · adult patients with harmful or hazardous alcohol or substance use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Functional impairment · adult patients with harmful or hazardous alcohol or substance use
1 finding from 1 review
Service utilisation ‐ unplanned hospitalisations (1 to 6 months post intervention) (RR < 1 denotes lower risk) · adult patients with harmful or hazardous alcohol or substance use
It is very uncertain whether lay health worker‐led interventions for adult patients with harmful… changes service utilisation ‐ unplanned hospitalisations (1 to 6 months post… compared with enhanced usual care (very low certainty).
1 finding from 1 review
Adverse events ‐ death in past 12 months (RR > 1 denotes higher risk of death) · adult patients with harmful or hazardous alcohol or substance use
It is very uncertain whether lay health worker‐led interventions for adult patients with harmful… changes adverse events ‐ deaths (RR < 1 denotes lower risk) compared with enhanced usual care (very low certainty).
1 finding from 1 review
Patient involvement in decision‐making · older patients with multi‐morbidity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health status (a) Patient‐reported high self‐rated health at 6 months after baseline CDC Healthy Days Measure (CDC 2000): dichotomised as low (1 to 3) and high (4 to 5) · older patients with multi‐morbidity
It is very uncertain whether interventions for involving older patients with multi‐morbidity in… changes health status (a) Patient‐reported high self‐rated health at 6… compared with usual care (very low certainty).
1 finding from 1 review
Health status and quality of life · older patients with multi‐morbidity
1 finding from 1 review
Patient Activation Measure (PAM) · older patients with multi‐morbidity
1 finding from 1 review
Patient enablement and engagement (b) Morisky Medication Adherence Scale at 15 months after baseline (8‐item yes‐no survey. Range of scores from 0 to 8. Lower scores suggest non‐adherence) (Morisky 2008) · older patients with multi‐morbidity
1 finding from 1 review
Participants' evaluation of the intervention · older patients with multi‐morbidity
Interventions for involving older patients with multi‐morbidity in… probably leads to higher patient evaluation of care/the intervention Care related to patient… compared with usual care (moderate certainty).
1 finding from 1 review
Practitioners' knowledge and skills Not measured · older patients with multi‐morbidity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resource use and cost Number of nurse consultations at 15 months after baseline (extracted from patients’ routine electronic medical records) · older patients with multi‐morbidity
Interventions for involving older patients with multi‐morbidity in… probably leads to higher resource use and cost Number of nurse consultations at 15 months… compared with usual care (moderate certainty).
1 finding from 1 review
Adverse event** Less patient involvement as a result of the intervention Not measured · older patients with multi‐morbidity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Myocardial infarction · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in myocardial infarction compared with placebo or standard care (high certainty).
1 finding from 1 review
Stroke · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… leads to lower stroke compared with placebo or standard care (high certainty).
1 finding from 1 review
Death by any cause · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in death by any cause compared with placebo or standard care (high certainty).
1 finding from 1 review
Adverse events · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in adverse events compared with placebo or standard care (high certainty).
1 finding from 1 review
Incremental cost‐effectiveness · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
1 finding from 1 review
Self-efficacy related to oral health · school‐age children and adolescents
Theory-based educational interventions significantly improved oral health self-efficacy (SMD 1.49; low certainty), though between-study heterogeneity was very high.
1 finding from 1 review
Oral health attitudes (1-7 scale) · school‐age children and adolescents
Theory-based interventions significantly improved oral health attitude (SMD 9.32; low certainty); the very large effect warrants cautious interpretation.
1 finding from 1 review